Blackstone Life Sciences invests $250M in Anagram Therapeutics to advance ANG003, a novel oral enzyme therapy for pancreatic insufficiency. Learn more.
Popular Searches:
Recommended Posts
Search Results
Blackstone Life Sciences invests $250M in Anagram Therapeutics to advance ANG003, a novel oral enzyme therapy for pancreatic insufficiency. Learn more.
The Hero Group acquires UK gut health snack company The Gut Stuff, expanding its Better Snacking portfolio. Read about the strategic deal and market impact.
